Skip to content

APOTHEEK GLORIE: what changed

BE 0434.606.718NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€5,029
2024 · €16,138-€11,109
Equity
€271,931
2024 · €266,902+€5,029
Cash
€190,211
2024 · €199,493-€9,282
Balance sheet total
€402,512
2024 · €397,314+€5,197

Largest movements

2024 to 2025
Assets
  • Cash -€9,282

    down €9,282 (-4.7%), from €199,493 to €190,211

    mainly Investment in fixed assets (net) (-€8,551) and Receivables within one year (-€6,936)

  • Receivables within one year +€6,936

    up €6,936 (+15.1%), from €45,849 to €52,785

    of which Other amounts receivable: +€4,608

  • Tangible fixed assets +€5,380

    up €5,380 (+38.9%), from €13,847 to €19,227

    of which Plant, machinery and equipment: +€2,698

Equity and liabilities
  • Reserves +€5,029

    up €5,029 (+2.0%), from €248,302 to €253,331

Income statement
  • Gross operating margin -€13,591

    down €13,591 (-21.5%), from €63,086 to €49,495

  • Taxes -€3,735

    down €3,735 (-67.6%), from €5,527 to €1,792

  • Staff costs +€1,337

    up €1,337 (+4.4%), from €30,523 to €31,859

  • Financial charges -€1,029

    down €1,029 (-11.8%), from €8,743 to €7,714

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €16,138
Gross operating margin -€13,591
Staff costs -€1,337
Depreciation -€525
Other operating charges -€91
Financial income -€331
Financial charges +€1,029
Taxes +€3,735
Result 2025 €5,029
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€731
Investment -€8,551
Financing €0
Cash 2024 €199,493
Net result for the year +€5,029
Depreciation +€3,518
Stocks and contracts -€2,681
Receivables within one year -€6,936
Deferred charges and accrued income +€170
Trade debts +€1,151
Tax, wage and social debts -€519
Other debts +€320
Accrued charges and deferred income -€783
Investment in fixed assets (net) -€8,551
Cash 2025 €190,211
brings cash intakes cash out
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €397,314 €402,512 +€5,197 +1.3%
Fixed assets 21/28 €14,946 €19,978 +€5,033 +33.7%
Intangible fixed assets 21 €1,099 €752 -€347 -31.6%
Tangible fixed assets 22/27 €13,847 €19,227 +€5,380 +38.9%
Plant, machinery and equipment 23 €13,847 €16,545 +€2,698 +19.5%
Furniture and vehicles 24 - €2,681 +€2,681
Current assets 29/58 €382,369 €382,533 +€165 0.0%
Stocks and contracts in progress 3 €109,527 €112,208 +€2,681 +2.4%
Stocks 30/36 €109,527 €112,208 +€2,681 +2.4%
Amounts receivable within one year 40/41 €45,849 €52,785 +€6,936 +15.1%
Trade receivables 40 €42,035 €44,363 +€2,328 +5.5%
Other amounts receivable 41 €3,814 €8,422 +€4,608 +121%
Current investments 50/53 €20,878 €20,878 = 0.0%
Cash at bank and in hand 54/58 €199,493 €190,211 -€9,282 -4.7%
Deferred charges and accrued income 490/1 €6,621 €6,451 -€170 -2.6%
Total equity and liabilities 10/49 €397,314 €402,512 +€5,197 +1.3%
Equity 10/15 €266,902 €271,931 +€5,029 +1.9%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €248,302 €253,331 +€5,029 +2.0%
Distributable reserves 133 €248,302 €253,331 +€5,029 +2.0%
Amounts payable 17/49 €130,412 €130,581 +€169 +0.1%
Amounts payable within one year 42/48 €123,615 €124,567 +€952 +0.8%
Trade debts 44 €31,101 €32,252 +€1,151 +3.7%
Suppliers 440/4 €31,101 €32,252 +€1,151 +3.7%
Taxes, remuneration and social security 45 €7,690 €7,171 -€519 -6.7%
Taxes 450/3 €394 €85 -€309 -78.5%
Remuneration and social security 454/9 €7,296 €7,086 -€210 -2.9%
Other amounts payable 47/48 €84,824 €85,144 +€320 +0.4%
Accrued charges and deferred income 492/3 €6,797 €6,014 -€783 -11.5%
Remuneration, social security and pensions 62 €30,523 €31,859 +€1,337 +4.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,994 €3,518 +€525 +17.5%
Other operating charges 640/8 €349 €440 +€91 +25.9%
Gross operating margin 9900 €63,086 €49,495 -€13,591 -21.5%
Operating profit (loss) 9901 €29,221 €13,678 -€15,543 -53.2%
Financial income 75/76B €1,188 €856 -€331 -27.9%
Recurring financial income 75 €1,188 €856 -€331 -27.9%
Financial charges 65/66B €8,743 €7,714 -€1,029 -11.8%
Recurring financial charges 65 €8,743 €7,714 -€1,029 -11.8%
Profit (loss) for the period before taxes 9903 €21,665 €6,820 -€14,845 -68.5%
Income taxes 67/77 €5,527 €1,792 -€3,735 -67.6%
Profit (loss) for the period 9904 €16,138 €5,029 -€11,109 -68.8%
Profit (loss) for the period to be appropriated 9905 €16,138 €5,029 -€11,109 -68.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€176,472 to €192,825

Midpoint €183,286 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €271,179
Capitalised earnings €81,764 to €114,470
Indication €176,472 to €192,825

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€271,931
Intangible fixed assets (21)
-€752
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€271,179

Capitalised earnings

net result for the year (9904)
2025
€5,029
2024
€16,138
2023
€13,175
2022
€7,860
2021
-€1,237
Average result
€11,447
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€81,764 / €95,392 / €114,470

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.